4 Ozempic (Semaglutide 0.25 mg, 0.5 mg, 1 mg, & 2 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity and overweight
But now theres a newer player: Bimzelx (bimekizumab), which got FDA approval in November 2024, for treatment of adults with moderate to severe hidradenitis suppurativa (HS)
Lifestyle Intervention Alone Intensive lifestyle programs (structured diet and exercise with professional support) typically produce 5-7% weight loss
Conclusion: Empowering Your Weight Loss Journey Choosing Ozempic for weight loss requires careful consideration and a proactive approach
Its a good idea for anyone on semaglutide to monitor these changes and speak with a healthcare provider if they have concerns
Like most treatments, it requires a lifestyle change